EdgeScore

CADL · Nasdaq

Candel Therapeutics, Inc.: financial statements

Financially weak · see the checkFigures in USD, fiscal years

Revenue and net income

Revenue 2020: $125KNet income 2020: -$17.7M2020Revenue 2021: $125KNet income 2021: -$36.1M2021Revenue 2022: $125KNet income 2022: -$18.8M2022
RevenueNet income

Operating and free cash flow

Operating cash flow 2020: -$9.1MFree cash flow 2020: -$10.5M2020Operating cash flow 2021: -$22.2MFree cash flow 2021: -$24.1M2021Operating cash flow 2022: -$31.4MFree cash flow 2022: -$32.7M2022
Operating cash flowFree cash flow

Margins

Operating 2020: -11048.0%Operating 2021: -20580.8%Operating 2022: -27777.6%Net 2020: -14144.0%Net 2021: -28899.2%Net 2022: -15035.2%202020212022
GrossOperatingNet

Returns

ROE 2021: -56.3%ROE 2022: -39.4%ROA 2020: -46.2%ROA 2021: -40.5%ROA 2022: -24.2%202020212022
ROEROICROA

Income statement

USD202020212022Last year
Revenue$125K$125K$125K+0%
Operating income-$13.8M-$25.7M-$34.7M-35%
EBITDA-$13.7M-$25.5M-$33.9M-33%
Interest expense——$1.7M
Income tax—$0$0
Net income-$17.7M-$36.1M-$18.8M+48%

Cash flow

USD202020212022Last year
Operating cash flow-$9.1M-$22.2M-$31.4M-41%
Capital expenditure$1.5M$1.8M$1.3M-29%
Free cash flow-$10.5M-$24.1M-$32.7M-36%
Depreciation & amortization$91.0K$232K$778K+235%

Balance sheet

USD202020212022Last year
Cash$35.1M$82.6M$70.1M-15%
Current assets$35.1M$84.9M$71.9M-15%
Total assets$38.3M$89.2M$77.7M-13%
Current liabilities$4.7M$5.4M$5.6M+5%
Financial debt$483K$560K—
Total liabilities$12.8M$25.1M$30.0M+20%
Shareholders' equity-$23.6M$64.1M$47.7M-26%
Net debt-$34.6M-$82.1M-$70.1M+15%

Ratios

202020212022Last year
Operating margin-11048.0%-20580.8%-27777.6%
Net margin-14144.0%-28899.2%-15035.2%
Return on equity—-56.3%-39.4%
Return on assets-46.2%-40.5%-24.2%
Debt / equity—0.01—
Interest coverage——-20.3x
Current ratio7.4615.8412.81
Quick ratio7.4615.8412.81

Data source: SEC EDGAR, company annual reports. Lines a company does not report are left empty. Free cash flow is operating cash flow minus capital expenditure. Ratios use the same formulas as the EdgeScore check.

For information and education only. Not investment advice. Data may contain errors.